Asthma Study for People Using High Dose Steroids

What we are studying

You have been asked to consider taking part in this study because you have severe asthma that is not well controlled. This study is being carried out to evaluate a new medicine to treat severe asthma compared with placebo (an inactive substance). Asthma is a lung disease associated with inflammation (swelling) of the air passages. Certain proteins made by the body, called interleukins, are thought to be important in causing inflammation. One of these proteins, interleukin-5 (IL-5), appears to play a major role in asthma. The study drug is an antibody made in the laboratory that has been made to block the effect of IL-5.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 75

Eligibility Criteria

  • Diagnosed with asthma for at least 1 year
  • Be using a high dose steroid in a combination product (like Advair or Symbicort)
  • Have 2 documented asthma episodes requiring oral steroids/a shot of steroids/hospitalization
  • Cannot have any other breathing problems
  • You cannot be pregnant or breast-feeding.

What is involved

  • 17 visits clinic visits over 62 weeks
  • 1 phone call visit

Contact Information

Study Coordinator
Bob Hmieleski
Email
bhmieles@wakehealth.edu
Phone
336-713-8550

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.